BriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7th Pharmaceutical Investing
BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling Pharmaceutical Investing
Avricore Health CEO Hector Bremner: Substantial Revenue Growth in 2023 with HealthTab™ Medical Device Investing
